JPS6126897B2 - - Google Patents
Info
- Publication number
- JPS6126897B2 JPS6126897B2 JP9469978A JP9469978A JPS6126897B2 JP S6126897 B2 JPS6126897 B2 JP S6126897B2 JP 9469978 A JP9469978 A JP 9469978A JP 9469978 A JP9469978 A JP 9469978A JP S6126897 B2 JPS6126897 B2 JP S6126897B2
- Authority
- JP
- Japan
- Prior art keywords
- trifluoro
- tolyl
- mol
- carried out
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 125000004494 ethyl ester group Chemical group 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 3
- LPEPZBJOKDYZAD-UHFFFAOYSA-N flufenamic acid Chemical compound OC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 LPEPZBJOKDYZAD-UHFFFAOYSA-N 0.000 claims description 2
- -1 hydroxyethoxy Chemical group 0.000 claims description 2
- 150000001447 alkali salts Chemical class 0.000 claims 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 239000003054 catalyst Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 6
- 239000003085 diluting agent Substances 0.000 description 5
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 5
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 238000007327 hydrogenolysis reaction Methods 0.000 description 4
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- BXLGCMGVRUDKQE-UHFFFAOYSA-N 2-(2-chloroethoxy)ethoxymethylbenzene Chemical compound ClCCOCCOCC1=CC=CC=C1 BXLGCMGVRUDKQE-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000000199 molecular distillation Methods 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- XADWAOQDMNPUEI-UHFFFAOYSA-N bis[2-(2-chloroethoxy)ethoxy]methylbenzene Chemical compound ClCCOCCOC(OCCOCCCl)C1=CC=CC=C1 XADWAOQDMNPUEI-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000005292 vacuum distillation Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- HUTXVUPGARJNHM-UHFFFAOYSA-N 1-(2-chloroethoxy)ethanol Chemical compound CC(O)OCCCl HUTXVUPGARJNHM-UHFFFAOYSA-N 0.000 description 1
- LECMBPWEOVZHKN-UHFFFAOYSA-N 2-(2-chloroethoxy)ethanol Chemical compound OCCOCCCl LECMBPWEOVZHKN-UHFFFAOYSA-N 0.000 description 1
- DNUPYEDSAQDUSO-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl benzoate Chemical compound OCCOCCOC(=O)C1=CC=CC=C1 DNUPYEDSAQDUSO-UHFFFAOYSA-N 0.000 description 1
- LJVNVNLFZQFJHU-UHFFFAOYSA-N 2-(2-phenylmethoxyethoxy)ethanol Chemical compound OCCOCCOCC1=CC=CC=C1 LJVNVNLFZQFJHU-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000004517 catalytic hydrocracking Methods 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- LJOODBDWMQKMFB-UHFFFAOYSA-N cyclohexyl-acetic acid Natural products OC(=O)CC1CCCCC1 LJOODBDWMQKMFB-UHFFFAOYSA-N 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229960003750 ethyl chloride Drugs 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000003402 intramolecular cyclocondensation reaction Methods 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 150000002895 organic esters Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- VLSHYHUKASKGPF-UHFFFAOYSA-M potassium;2-aminobenzoate Chemical compound [K+].NC1=CC=CC=C1C([O-])=O VLSHYHUKASKGPF-UHFFFAOYSA-M 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
本発明は、公知のN―(α,α,α―トリフル
オル―m―トリル)アントラニル酸―2―(2―
ヒドロキシエトキシ)エチルエステル()
の製造に対する改良方法に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention is directed to the use of known N-(α,α,α-trifluoro-m-tolyl)anthranilic acid-2-(2-
Hydroxyethoxy)ethyl ester() The present invention relates to an improved method for manufacturing.
化合物は、局所的に使用することができる抗
炎症剤および抗リウマチ剤としてINN(rec.)エ
トフエナマツトの名称下に公知であり、従来は西
ドイツ特許明細書1939112(実施例1)××××に
従つて、N―(α,α,α―トリフルオル―m―
トリル)アントラニル酸のカリウム塩()と2―
(2―クロルエトキシ)エタノール()から、下
記の反応式によつて表わすことのできる反応によ
り製造されている:
この際、当モル量のとをジメチルホルムア
ミド中に溶解し、2時間の間、沸とうさせ、沈殿
した塩化カリウムを別し、濃縮したのち、シク
ロヘキサン:氷酢酸(1:1)混合物を溶離剤と
して用いて、シリカゲルカラムによつて精製す
る。結晶化しない黄色油状物が得られる。 The compound is known under the name INN (rec.) Etofenamat as an anti-inflammatory and anti-rheumatic agent which can be used topically and was previously described in West German Patent Specification 1939112 (Example 1) Therefore, N-(α, α, α-trifluoro-m-
Tolyl) Potassium salt of anthranilic acid () and 2-
It is produced from (2-chloroethoxy)ethanol () by a reaction that can be expressed by the following reaction formula: At this time, an equimolar amount of and was dissolved in dimethylformamide, boiled for 2 hours, precipitated potassium chloride was separated, concentrated, and a mixture of cyclohexane and glacial acetic acid (1:1) was used as the eluent. and purified by silica gel column. A non-crystallized yellow oil is obtained.
このような製造方法は著しい欠点を有してい
る。たとえば、シリカゲルによる精製物は、下記
のような副生物を含有していることが追試によつ
て確かめられた:
分析と合成によつて確認されたこれらの副生物
は、技術的な尺度では確かに実施可能であるけれ
ども経済的にはきわめて費用のかかる方法である
分子蒸留を何回も繰返すことによつてきわめて困
難ながらようやく主生成物()から分離しうるの
みである。 Such manufacturing methods have significant drawbacks. For example, it was confirmed through additional tests that the product purified using silica gel contained the following by-products: These by-products, identified by analysis and synthesis, can be purified by repeated molecular distillations, a process that is certainly feasible on a technical scale but economically very expensive. It can only be separated from the main product () with difficulty.
別の欠点は、一方では転化率により、他方では
後処理により生ずる、比較的低い収率である。 Another drawback is the relatively low yield, which is caused by the conversion on the one hand and by the work-up on the other hand.
約80%の転化率に達するためには、出発化合物
()およ()を140〜155℃に加熱しなければなら
ない。しかしながら、このような温度において
は、更に他の副反応として、14―ジオキサンへの
()の分子内閉環が生ずる。 To reach a conversion of approximately 80%, the starting compound
() and () must be heated to 140-155°C. However, at such temperatures, another side reaction is the formation of 14-dioxane.
Intramolecular ring closure of () occurs.
公知の抗炎症剤N―(α,α,α―トリフルオ
ル―m―トリフル)アントラニル酸―2―(2―
ヒドロキシエトキシ)エチルエステルは、N―
(α,α,α―トリフルオ―m―トリル)アント
ラニル酸のアルカリ塩、特にカリウム塩()を、
一般式
式中Rは水素または基Cl―CH2―CH2―O―
CH2―CH2―O―を表わす、
の化合物と反応させ、次いで公知の方法による水
素添加分解によつてベンジル基を分解するとき
に、より良い収率で且つより高い純度で、取得し
うることが見出された。 Known anti-inflammatory agent N-(α,α,α-trifluoro-m-trifluor)anthranilic acid-2-(2-
Hydroxyethoxy)ethyl ester is N-
Alkali salts of (α,α,α-trifluoro-m-tolyl)anthranilic acid, especially potassium salts (),
general formula In the formula, R is hydrogen or a group Cl—CH 2 —CH 2 —O—
can be obtained in better yields and in higher purity when reacting with a compound representing CH 2 —CH 2 —O— and then decomposing the benzyl group by hydrogenolysis according to known methods. It was discovered that
本発明による反応は、たとえば、下記の反応経
過によつて表わすことができる:
出発化合物として使用する化合物()は文献に
公知であるが、一般式()の出発物質は、未だ本
献には記されていない。これらは下記の方法によ
つて容易に製造することができる:
a 公知の2―(2―ベンゾイルオキシエトキ
シ)エタノールを、塩基性の酸結合剤、好まし
くはピリジンの存在において、加熱下に塩化チ
オニルと反応させることによつて、2―(2―
ベンジロキシエトキシ)エチルクロリド(、
R=H)を生成せしめる;
b ベンズアルデヒドを、希釈剤および触媒、好
ましくはp―トルエンスルホン酸、の存在にお
いて、2―(2―ヒドロキシエトキシ)エチル
クロリドと共に、沸とう温度において連続的な
水の分離下に加熱し、それによつてビス〔2―
(クロロエトキシ)エトキシ〕トルエン(、
R=O―CH2―CH2―O―CH2―CH2―Cl)を
生成せしめる。 The reaction according to the invention can be represented, for example, by the following reaction sequence: The compounds () used as starting compounds are known in the literature, but the starting materials of the general formula () have not yet been described in this publication. These can be easily prepared by the following method: a. The known 2-(2-benzoyloxyethoxy)ethanol is converted into thionyl chloride under heat in the presence of a basic acid binder, preferably pyridine. By reacting with 2-(2-
Benzyloxyethoxy)ethyl chloride (,
R=H); b benzaldehyde is mixed with 2-(2-hydroxyethoxy)ethyl chloride in the presence of a diluent and a catalyst, preferably p-toluenesulfonic acid, in a continuous stream of water at the boiling temperature. heating under separation, thereby bis[2-
(chloroethoxy)ethoxy]toluene (,
R=O—CH 2 —CH 2 —O—CH 2 —CH 2 —Cl).
カリウム塩()と一般式()の化合物との反応
は、希釈剤の存在において、行なうことが好まし
い。希釈剤としては、すべての不活性有機溶剤を
考慮することができる。好適なものとしては、ベ
ンゼン、トルエン、キシレンのような炭化水素、
グリコールジメチルエーテル、ジオキサンのよう
な高級エーテル、特にジメチルホルムアミド、ジ
メチルスルホキシドおよびヘキサメチル燐酸トリ
アミドのような非プロトン性溶剤を挙げることが
できる。 The reaction between the potassium salt () and the compound of general formula () is preferably carried out in the presence of a diluent. All inert organic solvents can be considered as diluents. Preferred are hydrocarbons such as benzene, toluene, xylene,
Mention may be made of higher ethers such as glycol dimethyl ether, dioxane, and in particular aprotic solvents such as dimethylformamide, dimethylsulfoxide and hexamethylphosphoric triamide.
反応温度は広い範囲で変えることができる。通
常は約50℃乃至約200℃、好ましくは90℃乃至150
℃において行なう。 The reaction temperature can be varied within a wide range. Usually about 50℃ to about 200℃, preferably 90℃ to 150℃
Perform at ℃.
反応は常圧において、あるいは加圧下に行なう
ことができる。通常は常圧において行なう。 The reaction can be carried out at normal pressure or under increased pressure. It is usually carried out at normal pressure.
本発明の方法の遂行において、化合物(R=
H)を用いる場合には、1モルのカリウム塩に
対して少なくとも1モルを使用する。しかし、僅
かに過剰の(R=H)を使用することが好都合
である。 In carrying out the method of the invention, a compound (R=
If H) is used, at least 1 mol is used per mol of potassium salt. However, it is advantageous to use a slight excess (R=H).
化合物(R=O―CH2―CH2―O―CH2―
CH2―Cl)の使用下の本発明の方法の遂行におい
ては、1モルの()に対して少なくとも1/2モル
の()を使用するが、この場合にも、()を僅か
に過剰に使用することが好ましい。 Compound (R=O-CH 2 -CH 2 -O-CH 2 -
In carrying out the process of the invention using CH 2 -Cl), at least 1/2 mole of () is used for each mole of (), again with a slight excess of (). It is preferable to use it.
反応溶液の後処理は、溶剤を蒸発させ、塩化ア
ルカリを溶解しない適当な溶剤中に残渣を取り、
塩化アルカリを別し、溶剤を蒸発させたのち、
真空蒸留するかまたは適当な吸着剤により精製す
ることによつて、行なう。 Post-treatment of the reaction solution involves evaporating the solvent, taking the residue in a suitable solvent that does not dissolve alkali chloride, and
After separating the alkali chloride and evaporating the solvent,
This is carried out by vacuum distillation or purification with a suitable adsorbent.
このようにして製造した一般式
上式中でmは1または2の数を表わし且つX
は、m=2の場合は、1個の水素原子を意味し、
あるいはXは、m=1の場合は、2個の水素原子
を表わす、
の中間生成物を、次いで水素添加分解による開裂
反応に服せしめる。 General formula produced in this way In the above formula, m represents the number 1 or 2, and
means one hydrogen atom when m=2,
Alternatively, X represents two hydrogen atoms when m=1. The intermediate product of is then subjected to a cleavage reaction by hydrogenolysis.
この反応は、希釈剤中で行なうことが好まし
い。希釈剤としては、反応物を溶解し且つそれ自
体は水素化を受けることとがない、あらゆる溶剤
を使用することができる。たとえば、メタノー
ル、エタノール、イソプロパノールのようなアル
コール、酢酸メチル、酢酸エチル、酢酸イソプロ
ピル、好ましくは酢酸エチルのような低分子有機
エステルを挙げることができる。 This reaction is preferably carried out in a diluent. As diluent any solvent can be used that dissolves the reactants and does not itself undergo hydrogenation. Examples include alcohols such as methanol, ethanol, and isopropanol, and low-molecular organic esters such as methyl acetate, ethyl acetate, isopropyl acetate, preferably ethyl acetate.
水素添加分解は、触媒の存在における水素の導
入によつて行なう。触媒としては、周期表の8族
の金属。、好ましくはパラジウム、を考慮するこ
とができる。 Hydrocracking is carried out by introducing hydrogen in the presence of a catalyst. Catalysts include metals from group 8 of the periodic table. , preferably palladium.
温度は、一定の範囲内で変えることができる。
一般に約15〜40℃、好ましくは20〜30℃において
行なう。 The temperature can be varied within certain limits.
It is generally carried out at a temperature of about 15-40°C, preferably 20-30°C.
水素添加分解は、常圧において、あるいはまた
加圧下に、行なうことができる。一般には、常圧
において行なう。 Hydrogenolysis can be carried out at normal pressure or also under pressure. Generally, it is carried out at normal pressure.
本発明による合成は文献に公知の方法に比して
一連の利点を有している:エステル化に際して遊
離OH基をエーテル化によりブロツクすることに
よつて、エステル化が副反応なしで、より良い収
率で進行する。かくして、経済的に且つ設備的に
やつかいな何回もの分子蒸留によつて分離しなけ
ればならない副生物は、生成しない。 The synthesis according to the invention has a number of advantages over the methods known in the literature: By blocking the free OH groups during the esterification by etherification, the esterification can be carried out without side reactions and better. Proceed with yield. Thus, no by-products are produced which must be separated by multiple economically and equipment-intensive molecular distillations.
中間生成物の水素添加分解は、ほとんど定量的
に進んで、たとえば分子蒸留のような費用のかか
る精製手段をもはや必要としない、純粋な最終生
成物を与える。 The hydrogenolysis of the intermediate product proceeds almost quantitatively to give a pure final product, which no longer requires expensive purification measures such as, for example, molecular distillation.
実施例;
N―(α,α,α―トリフルオル―m―トリ
ル)アントラニル酸―2―(2―ヒドロキシエ
トキシ)エチルエステル
1 a 2―(2―ベンジロキシエトキシ)エチ
ルクロリド
294g(1.5モル)の2―(2―ベンジロキシエ
トキシ)エタノールと119g(1.5モル)のピリジ
ンを、−20℃に冷却したのち、178g(1.5モル)の
塩化チオニルを撹拌下に滴下して反応させる。低
温において更に1/2時間撹拌したのち、反応溶液
を更に2時間80℃に加温し、次いで、氷と2n塩
酸の混合物中に入れる。次いで、水相をジクロル
メタンによつて抽出し、抽出物を数回水洗し、硫
酸ナトリウム上で乾燥したのち、蒸発させる。分
別蒸留によつて、270g(=83.8%)の2―(2―
ベンジロキシエトキシ)エチルクロリドを取得す
る。Example; N-(α,α,α-trifluoro-m-tolyl)anthranilic acid-2-(2-hydroxyethoxy)ethyl ester 1 a 2-(2-benzyloxyethoxy)ethyl chloride 294 g (1.5 mol) After cooling 2-(2-benzyloxyethoxy)ethanol and 119 g (1.5 mol) of pyridine to -20°C, 178 g (1.5 mol) of thionyl chloride is added dropwise with stirring to react. After stirring for an additional 1/2 hour at low temperature, the reaction solution is warmed to 80° C. for a further 2 hours and then placed in a mixture of ice and 2N hydrochloric acid. The aqueous phase is then extracted with dichloromethane, the extracts are washed several times with water, dried over sodium sulfate and evaporated. By fractional distillation, 270g (=83.8%) of 2-(2-
Obtain benzyloxyethoxy)ethyl chloride.
沸点84〜86℃/0.05mmHg;n20 D1.5100。 Boiling point 84-86°C/0.05mmHg; n20D 1.5100 .
b 2―(2―ベンジロキシエトキシ)エチル―
N―(α,α,α―トリフルオル―m―トリ
ル)アントラニラート
1.4のジメチルホルムアミド中に溶解した
319g(1モル)のN―(α,α,α―トリフル
オル―m―トリル)アントラニル酸のカリウム塩
()中に、247g(1.15モル)の2―(2―ベンジ
ロキシエトキシ)エチルクロリドを滴下し、10時
間煮沸する。溶剤の蒸発除去後に、残渣を3の
トルエン中に取り、沈殿した塩化カリウムを別
し、有機相を数回800mlの2n炭酸ナトリウム溶液
により洗浄し、次いで水により洗浄し、硫酸ナト
リウム上で乾燥したのち、濃縮する。真空蒸留後
に、沸点190〜200℃/0.0001の331g(=72%)の
2―(2―ベンジロキシエトキシ)エチル―N―
(α,α,α―トリフルオル―m―トリル)アン
トラニラートを取得する。b 2-(2-benzyloxyethoxy)ethyl-
N-(α,α,α-trifluoro-m-tolyl)anthranilate dissolved in 1.4 dimethylformamide
319 g (1 mol) of the potassium salt of N-(α,α,α-trifluoro-m-tolyl)anthranilic acid
247 g (1.15 mol) of 2-(2-benzyloxyethoxy)ethyl chloride was added dropwise into the solution and boiled for 10 hours. After evaporation of the solvent, the residue was taken up in 3 toluene, the precipitated potassium chloride was separated off, and the organic phase was washed several times with 800 ml of 2N sodium carbonate solution, then with water and dried over sodium sulfate. Later, it is concentrated. After vacuum distillation, 331 g (=72%) of 2-(2-benzyloxyethoxy)ethyl-N- with a boiling point of 190-200°C/0.0001
(α, α, α-trifluoro-m-tolyl) anthranilate is obtained.
C25H24F3NO4(459.48)
計算値:C65.35%、H5.27%、F12.41%、N3.05
%;
分析値:C65.64%、H5.33%、F12.30%、N3.14
%。C 25 H 24 F 3 NO 4 (459.48) Calculated values: C65.35%, H5.27%, F12.41%, N3.05
%; Analysis value: C65.64%, H5.33%, F12.30%, N3.14
%.
c 230g(0.5モル)の前記bの化合物を、15
のメタノール/酢酸エチルの1:1混合物中に
溶解し、5gの炭素上パラジウム触媒(10%)
を加えたのち、20℃、750トルにおいて、水素
添加する。水素の吸収の終了後に、触媒を別
し、液を50gの活性炭と共に50℃に加温し、
過し、濃縮したのち、ネルケスマイヤー
(No″lkesmeyer)の薄層装置中で脱気する。
174.5g(=94.5%)のN―(α,α,α―トリ
フルオル―m―トリル)アントラニル酸―2―
(2―ヒドロキシエトキシ)エチルエステルを
取得する。c 230g (0.5 mol) of the compound b above, 15
5 g of palladium on carbon catalyst (10%) dissolved in a 1:1 mixture of methanol/ethyl acetate
After adding , hydrogenate at 20℃ and 750 torr. After hydrogen absorption is completed, the catalyst is separated and the liquid is heated to 50℃ with 50g of activated carbon.
After filtration and concentration, it is degassed in a No″lkesmeyer thin layer apparatus.
174.5g (=94.5%) of N-(α,α,α-trifluoro-m-tolyl)anthranilic acid-2-
(2-hydroxyethoxy)ethyl ester is obtained.
2 a ビス〔2―(2―クロルエトキシ)エト
キシ〕トルエン
1のトルエン中に溶解した106g(1モル)
のベンズアルデヒドと298g(4モル)の2―
(2―ヒドロキシエトキシ)エタノールを、1gの
p―トルエンスルホン酸の存在において、生成す
る水を連続的に除去しながら、14時間煮沸する。
冷却後に、反応溶液をナトリウムメチラートによ
つて中和し、溶液を濃縮し、残渣を高真空で蒸留
する。沸点125〜135℃/0.0001の208g(61.7%)
のビス〔2―(2―クロルエトキシ)エトキシ〕
トルエンを取得する。2 a Bis[2-(2-chloroethoxy)ethoxy]toluene 106 g (1 mol) dissolved in 1 toluene
of benzaldehyde and 298 g (4 moles) of 2-
(2-Hydroxyethoxy)ethanol is boiled for 14 hours in the presence of 1 g of p-toluenesulfonic acid, with continuous removal of the water formed.
After cooling, the reaction solution is neutralized with sodium methylate, the solution is concentrated and the residue is distilled under high vacuum. 208g (61.7%) with boiling point 125-135℃/0.0001
Bis[2-(2-chloroethoxy)ethoxy]
Obtain toluene.
C15H22Cl2O4(337.27) 計算値:C53.42%、H6.58%、Cl21.03%; 分析値:C53.65%、H6.86%、Cl20.73%。C 15 H 22 Cl 2 O 4 (337.27) Calculated values: C53.42%, H6.58%, Cl21.03%; Analytical values: C53.65%, H6.86%, Cl20.73%.
b α,α―ビス―{2―〔2―(N―(α,
α,α―トリフルオルル―m―トリル)アント
ラニロイルオキシ)エトキシ〕エトキシ}トル
エン
上記aにおいて製造した化合物185g(0.55モ
ル)を、50℃においてヘキサメチル燐酸トリアミ
ド中に溶解し、319g(1モル)のN―(α,
α,α―トリフルオル―m―トリル)アントラニ
ル酸カリウムを加えたのち、撹拌下に20時間95℃
で加温する。溶剤の留去後に、残渣を1のアセ
トン中に溶解し、300gの酸化アルミニウム上で
過し、濃縮したのち、ネルケスヤイヤーの薄層
装置中で脱気する。341g(=82.5%)のα,α―
ビス―{2―〔2―(N―(α,α,α―トリフ
ルオル―m―トリル)アントラニロイロキシ)エ
トキシ〕エトキシ}トルエンを取得する。b α,α-bis-{2-[2-(N-(α,
α,α-Trifluorol-m-tolyl)anthraniloyloxy)ethoxy]ethoxy}toluene 185g (0.55 mol) of the compound prepared in a above was dissolved in hexamethylphosphoric triamide at 50°C, and 319g (1 mol) N-(α,
After adding α,α-trifluoro-m-tolyl) potassium anthranilate, 95°C for 20 hours with stirring.
Warm it with After distilling off the solvent, the residue is dissolved in 1 part of acetone, filtered over 300 g of aluminum oxide, concentrated and then degassed in a Nelkesjayer thin layer apparatus. α,α― of 341g (=82.5%)
Bis-{2-[2-(N-(α,α,α-trifluoro-m-tolyl)anthraniloyloxy)ethoxy]ethoxy}toluene is obtained.
C43H40F6N2O8(826.81) 計算値:C62.46%、H4.88%、N3.39%: 分析値:C62.75%、H5.48%、N3.26%。C 43 H 40 F 6 N 2 O 8 (826.81) Calculated values: C62.46%, H4.88%, N3.39% Analyzed values: C62.75%, H5.48%, N3.26%.
c 上記bの化合物165g(0.2モル)を、精製さ
れたた粗生成物として500mlのメタノール中に
溶解し、25℃において15gの10%炭素上パラジ
ウム触媒を添加したのち、756トルにおいて水
素吸収の終了に至るまで、水素添加する。次い
で触媒を別し、溶剤を留去し、残渣を薄層装
置中で脱気する。136g(=92%)のN―
(α,α,α―トリフルオル―m―トリル)ア
ントラニル酸―2―(2―ヒドロキシエトキ
シ)エチルエステルを取得する。c 165 g (0.2 mol) of the compound from b above were dissolved in 500 ml of methanol as purified crude product and after addition of 15 g of 10% palladium on carbon catalyst at 25°C, hydrogen absorption at 756 torr was carried out. Hydrogenate until completion. The catalyst is then separated off, the solvent is distilled off and the residue is degassed in a thin-layer apparatus. 136g (=92%) of N-
(α,α,α-trifluoro-m-tolyl)anthranilic acid-2-(2-hydroxyethoxy)ethyl ester is obtained.
Claims (1)
ル)アントラニル酸のアルカリ塩を、一般式 式中Rは水素または基―O―CH2―CH2―O―
CH2―CH2―Clを表わす、 の化合物と反応させて、一般式 式中mは1およ2の数を表わし且つXは、m=
2の場合には、1個の水素原子を表わし、または
m=1の場合には、2個の水素原子を表わす、 の化合物を生成せしめ、これを水素添加分解する
ことを特徴とする、N―(α,α,α―トリフル
オル―m―トリル)アントラニル酸―2―(2―
ヒドロキシエトキシ)エチルエステルの製造方
法。 2 90〜150℃の温度において行なう、特許請求
の範囲第1項記載の方法。[Scope of Claims] 1 An alkali salt of N-(α,α,α-trifluoro-m-tolyl)anthranilic acid has the general formula In the formula, R is hydrogen or a group -O-CH 2 -CH 2 -O-
CH 2 —CH 2 —Cl is reacted with a compound of the general formula In the formula, m represents the numbers 1 and 2, and X is m=
In the case of 2, it represents one hydrogen atom, or in the case of m=1, it represents two hydrogen atoms. -(α,α,α-trifluoro-m-tolyl)anthranilic acid-2-(2-
Method for producing hydroxyethoxy)ethyl ester. 2. The method according to claim 1, which is carried out at a temperature of 90 to 150°C.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19772735569 DE2735569A1 (en) | 1977-08-06 | 1977-08-06 | Antiinflammatory and antirheumatic agent prodn. - esp. N-tri:fluoro:methyl-phenyl-anthranilic acid hydroxy-ethoxy-ethyl ester |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5430130A JPS5430130A (en) | 1979-03-06 |
| JPS6126897B2 true JPS6126897B2 (en) | 1986-06-23 |
Family
ID=6015831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9469978A Granted JPS5430130A (en) | 1977-08-06 | 1978-08-04 | Process for preparing nn*alpha*alpha*alphaatrifluoroommtolyl** anthranylatee22*22hydroxyethoxy** ethylester |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS5430130A (en) |
| DE (1) | DE2735569A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES8605220A1 (en) * | 1985-10-25 | 1986-03-16 | Espanola Prod Quimicos | Esters of diethylene glycol |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1939112C3 (en) * | 1969-08-01 | 1975-03-06 | Troponwerke Dinklage & Co, 5000 Koeln | Esters of N- (3-trifluoromethylphenyl) anthranilic acid, process for their preparation and pharmacologically active preparations thereof |
| DE2734771C3 (en) * | 1977-08-02 | 1981-08-06 | Troponwerke GmbH & Co KG, 5000 Köln | N- (alpha, α, α-trifluoro-m-tolyl) anthranilic acid derivatives, processes for their preparation and anti-inflammatory pharmacological preparations containing these derivatives |
-
1977
- 1977-08-06 DE DE19772735569 patent/DE2735569A1/en active Granted
-
1978
- 1978-08-04 JP JP9469978A patent/JPS5430130A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5430130A (en) | 1979-03-06 |
| DE2735569A1 (en) | 1979-02-15 |
| DE2735569C2 (en) | 1988-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112174823B (en) | Intermediate for synthesizing 2, 2-dimethyl-3-oxetanone and preparation method and application thereof | |
| JP2003300943A (en) | Recovery method of triethylamine | |
| JPS6126897B2 (en) | ||
| CN109535120B (en) | Preparation method of 7-substituted-3,4,4,7-tetrahydrocyclobutanocoumarin-5-one | |
| JPS5915901B2 (en) | Method for producing u↓-amino alcohol | |
| JP3663427B2 (en) | Process for producing cyanofluorophenol | |
| JPH021827B2 (en) | ||
| EP0877023B1 (en) | Process for the preparation of aromatic compounds containing a heterocyclic system | |
| KR102632488B1 (en) | Synthetic method for 3,3-bis(bromomethyl)oxetane via continuous flow chemistry | |
| US2806048A (en) | 6, 8-dihydroxyoctanoic acid and related compounds | |
| CN109574894B (en) | (1) synthetic method of a kind of N-(3-(dimethylamino)-3-propanesulfanyl)-substituted benzamide | |
| JP2640688B2 (en) | Carbamate derivatives and methods for their production | |
| JPS584698B2 (en) | Method for producing 2-(3-benzoylphenyl)propionic acid | |
| JP3009860B2 (en) | Method for producing (±) 2- [4- (2-oxocyclopentylmethyl) phenyl] propionic acid and salts thereof | |
| EP0138575B1 (en) | Process for the preparation of 2,3-cis-1,2,3,4-tetrahydro-5-[(2-hydroxy-3-tert.butylamino)propoxy]-2,3-naphthalenediol and new intermediate for use therein | |
| JPS59222430A (en) | Fluorocyclopropane derivative | |
| EP0257309B1 (en) | Process for the preparation of ethynylbenzaldehydes | |
| JPS6259707B2 (en) | ||
| JPS6056139B2 (en) | Method for producing cyanoguanidine derivatives | |
| JPH0142951B2 (en) | ||
| JP2791572B2 (en) | Macrocyclic compound and method for producing the same | |
| JP2026501856A (en) | Process for preparing tetrahydro-1-naphthylamine and its derivatives | |
| JPS6151575B2 (en) | ||
| JPH027583B2 (en) | ||
| JP2729315B2 (en) | Method for producing 4-alkoxy-2-fluorophenylacetylene |